Zacks Research Brokers Decrease Earnings Estimates for CLB

Core Laboratories Inc. (NYSE:CLB) – Stock analysts at Zacks Research cut their Q4 2024 earnings per share (EPS) estimates for shares of Core Laboratories in a research report issued to clients and investors on Wednesday, December 4th. Zacks Research analyst T. Saha now forecasts that the oil and gas company will post earnings of $0.20 per share for the quarter, down from their previous forecast of $0.21. The consensus estimate for Core Laboratories’ current full-year earnings is $0.80 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2025 earnings at $0.22 EPS, Q2 2025 earnings at $0.26 EPS, Q3 2025 earnings at $0.29 EPS, Q4 2025 earnings at $0.23 EPS and Q2 2026 earnings at $0.28 EPS.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The business had revenue of $134.40 million for the quarter, compared to the consensus estimate of $134.16 million. During the same period in the prior year, the company posted $0.22 earnings per share. Core Laboratories’s revenue was up 7.2% compared to the same quarter last year.

Several other brokerages have also recently weighed in on CLB. Citigroup dropped their price objective on Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a report on Thursday, October 31st. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $17.00.

Core Laboratories Trading Down 2.5 %

Shares of CLB stock opened at $19.36 on Friday. The stock has a market cap of $908.95 million, a P/E ratio of 29.60, a price-to-earnings-growth ratio of 1.39 and a beta of 2.35. Core Laboratories has a 1 year low of $13.82 and a 1 year high of $25.13. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55. The stock has a 50 day simple moving average of $19.63 and a 200 day simple moving average of $19.62.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Monday, November 4th were paid a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.21%. The ex-dividend date of this dividend was Monday, November 4th. Core Laboratories’s dividend payout ratio (DPR) is presently 6.15%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Headlands Technologies LLC bought a new stake in shares of Core Laboratories during the 2nd quarter valued at approximately $36,000. nVerses Capital LLC acquired a new position in shares of Core Laboratories during the third quarter worth $48,000. GAMMA Investing LLC increased its holdings in shares of Core Laboratories by 23.9% during the second quarter. GAMMA Investing LLC now owns 4,425 shares of the oil and gas company’s stock worth $90,000 after buying an additional 855 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Core Laboratories by 11.9% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock valued at $114,000 after acquiring an additional 600 shares during the last quarter. Finally, Signaturefd LLC grew its position in Core Laboratories by 12.8% during the 2nd quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company’s stock worth $137,000 after acquiring an additional 767 shares during the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.